PRÁTICAS INTEGRATIVAS EM SAÚDE NO TRATAMENTO DA DOENÇA DE PARKINSON: UMA REVISÃO SISTEMÁTICA
DOI:
https://doi.org/10.16891/718Resumo
A Doença de Parkinson (DP) é uma doença neurodegenerativa causada pela deterioração ou perda de células secretoras de dopamina na substância negra dos gânglios da base. Os sinais e sintomas característicos da DP suscitam a convivência com situações novas a cada dia. A instabilidade da doença e o fato de sabê-la ser incurável constituem uma realidade difícil a ser enfrentada de maneira resiliente ao longo da vida, acompanhando os indivíduos em suas relações e em seu cotidiano. Nesse cenário, surgem as Práticas Integrativas e Complementares em Saúde (PICs). A mudança no perfil epidemiológico da saúde, a redução das doenças infectocontagiosas, surgimento das doenças crônico-degenerativas, assim como o avanço na busca de tratamentos disponíveis no processo de cura do paciente e os efeitos colaterais dos tratamentos e das intervenções cirúrgicas contribuíram para o surgimento de um novo modelo com a disseminação de ideias complementares. Objetivamos discutir a presença de outros modelos e práticas integrativas de saúde na última década, quanto ao acompanhamento longitudinal da Doença de Parkinson, consoante a literatura. Artigos publicados entre 2009 e 2019 e indexados no banco de dados da CAPES foram selecionados para este trabalho de revisão. A estratégia de busca utilizada foi a partir das palavras-chave: “Parkinson” e “Práticas integrativas”, sendo incluídos, também, os seguintes limites: artigos em português, inglês e espanhol, disponíveis na íntegra de forma gratuita. Em seguida, os trabalhos foram submetidos ao protocolo de pesquisa PRISMA, tendo seus principais detalhes analisados nesta revisão sistemática.
Referências
ABELIOVICH, Asa; GITLER, Aaron D.. Defects in trafficking bridge Parkinson's disease pathology and genetics. Nature, [s.l.], v. 539, n. 7628, p.207-216, nov. 2016. Springer Science and Business Media LLC. http://dx.doi.org/10.1038/nature20414 .
ANANDHAN, Annadurai et al. Theaflavin, a black tea polyphenol, protects nigral dopaminergic neurons against chronic MPTP/probenecid induced Parkinson's disease. Brain Research, [s.l.], v. 1433, p.104-113, jan. 2012. Elsevier BV. http://dx.doi.org/10.1016/j.brainres.2011.11.021.
AZAM, Faizul et al. Molecular interaction studies of green tea catechins as multitarget drug candidates for the treatment of Parkinson’s disease: computational and structural insights. Network: Computation in Neural Systems, [s.l.], v. 26, n. 3-4, p.97-115, 2 out. 2015. Informa UK Limited. http://dx.doi.org/10.3109/0954898x.2016.1146416.
BALASH, Yacov et al. Medical Cannabis in Parkinson Disease. Clinical Neuropharmacology, [s.l.], v. 40, n. 6, p.268-272, 2017. Ovid Technologies (Wolters Kluwer Health). http://dx.doi.org/10.1097/wnf.0000000000000246
BELLISSIMO, M.I.; KOUZMINE, I.; FERRO, M.M.; OLIVEIRA, B.H.; CANTERAS, N.N. Is the unilateral lesion of the left substantia nigra pars compacta sufficient to induce working memory impairment in rats? Neurobiol. Learn. Mem., 82(2),150–8, 2007.
BETARBET, Ranjita et al. Mechanistic Approaches to Parkinson's Disease Pathogenesis. Brain Pathology, [s.l.], v. 12, n. 4, p.499-510, 5 abr. 2006. Wiley. http://dx.doi.org/10.1111/j.1750-3639.2002.tb00468.x.
BUSS, Paulo Marchiori. Promoção da saúde e qualidade de vida. Ciência & Saúde Coletiva, [s.l.], v. 5, n. 1, p.163-177, 2000. FapUNIFESP (SciELO). http://dx.doi.org/10.1590/s1413-81232000000100014.
CILIA, Roberto et al. Mucuna pruriens in Parkinson disease. Neurology, [s.l.], v. 89, n. 5, p.432-438, 5 jul. 2017. Ovid Technologies (Wolters Kluwer Health). http://dx.doi.org/10.1212/wnl.0000000000004175.
DONOYAMA, Nozomi; SUOH, Sachie; OHKOSHI, Norio. Effectiveness of Anma massage therapy in alleviating physical symptoms in outpatients with Parkinson's disease: A before-after study. Complementary Therapies In Clinical Practice, [s.l.], v. 20, n. 4, p.251-261, nov. 2014. Elsevier BV. http://dx.doi.org/10.1016/j.ctcp.2014.07.010.
FINSETH, Taylor Andrew et al. Self-Reported Efficacy of Cannabis and Other Complementary Medicine Modalities by Parkinson’s Disease Patients in Colorado. Evidence-based Complementary And Alternative Medicine, [s.l.], v. 2015, p.1-6, 2015. Hindawi Limited. http://dx.doi.org/10.1155/2015/874849.
FISHER, Ria et al. The effect of Banisteriopsis caapi (B. caapi) on the motor deficits in the MPTP-treated common marmoset model of Parkinson's disease. Phytotherapy Research, [s.l.], v. 32, n. 4, p.678-687, 24 jan. 2018. Wiley. http://dx.doi.org/10.1002/ptr.6017.
FOROGH, Bijan et al. Repeated sessions of transcranial direct current stimulation evaluation on fatigue and daytime sleepiness in Parkinson’s disease. Neurological Sciences, [s.l.], v. 38, n. 2, p.249-254, 31 out. 2016. Springer Nature. http://dx.doi.org/10.1007/s10072-016-2748-x.
HARTMANN, Andreas et al. Bee Venom for the Treatment of Parkinson Disease – A Randomized Controlled Clinical Trial. Plos One, [s.l.], v. 11, n. 7, p.1-15, 12 jul. 2016. Public Library of Science (PLoS). http://dx.doi.org/10.1371/journal.pone.0158235
KALARIA, Dhaval R. et al. Simultaneous controlled iontophoretic delivery of pramipexole and rasagiline in vitro and in vivo: Transdermal polypharmacy to treat Parkinson’s disease. European Journal Of Pharmaceutics And Biopharmaceutics, [s.l.], v. 127, p.204-212, jun. 2018. Elsevier BV. http://dx.doi.org/10.1016/j.ejpb.2018.02.031.
KINDRED, John H. et al. Cannabis use in people with Parkinson’s disease and Multiple Sclerosis: A web-based investigation. Complementary Therapies In Medicine, [s.l.], v. 33, p.99-104, ago. 2017. Elsevier BV. http://dx.doi.org/10.1016/j.ctim.2017.07.002.
LACRUZ, Sagrario Pérez-de. A bicentric controlled study on the effects of aquatic Ai Chi in Parkinson disease. Complementary Therapies In Medicine, [s.l.], v. 36, p.147-153, fev. 2018. Elsevier BV. http://dx.doi.org/10.1016/j.ctim.2017.12.001.
LIMA, Karla Morais Seabra Vieira; SILVA, Kênia Lara; TESSER, Charles Dalcanale. Práticas integrativas e complementares e relação com promoção da saúde: experiência de um serviço municipal de saúde. Interface - Comunicação, Saúde, Educação, [s.l.], v. 18, n. 49, p.261-272, 10 mar. 2014. FapUNIFESP (SciELO). http://dx.doi.org/10.1590/1807-57622013.0133.
LIN, Jaung-geng et al. Electroacupuncture Promotes Recovery of Motor Function and Reduces Dopaminergic Neuron Degeneration in Rodent Models of Parkinson’s Disease. International Journal Of Molecular Sciences, [s.l.], v. 18, n. 9, p.1846-1859, 24 ago. 2017. MDPI AG. http://dx.doi.org/10.3390/ijms18091846.
LOTAN, Itay et al. Cannabis (Medical Marijuana) Treatment for Motor and Non–Motor Symptoms of Parkinson Disease. Clinical Neuropharmacology, [s.l.], v. 37, n. 2, p.41-44, 2014. Ovid Technologies (Wolters Kluwer Health). http://dx.doi.org/10.1097/wnf.0000000000000016.
MICHELS, Kristi et al. “Dance Therapy” as a psychotherapeutic movement intervention in Parkinson’s disease. Complementary Therapies In Medicine, [s.l.], v. 40, p.248-252, out. 2018. Elsevier BV. http://dx.doi.org/10.1016/j.ctim.2018.07.005.
MODUGNO, Nicola et al. Active Theater as a Complementary Therapy for Parkinson's Disease Rehabilitation: A Pilot Study. The Scientific World Journal, [s.l.], v. 10, p.2301-2313, 2010. Hindawi Limited. http://dx.doi.org/10.1100/tsw.2010.221.
MOHER, David et al. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. Plos Medicine, [s.l.], v. 6, n. 7, p.1-6, 21 jul. 2009. Public Library of Science (PLoS). http://dx.doi.org/10.1371/journal.pmed.1000097.
NðÑEZ, Fabiana et al. PBF509, an Adenosine A2A Receptor Antagonist With Efficacy in Rodent Models of Movement Disorders. Frontiers In Pharmacology, [s.l.], v. 9, p.1-10, 19 out. 2018. Frontiers Media SA. http://dx.doi.org/10.3389/fphar.2018.01200.
PALACIOS, Lucía Argandoña et al. Trastornos no motores de la enfermedad de Parkinson: introducción y generalidades. Revista de Neurología, [s.l.], v. 50, n. 02, p.1-5, 08 fev. 2010. Viguera Editores SLU. http://dx.doi.org/10.33588/rn.50s02.2009733 .
ROCHA, Priscila A. et al. Dance is more than therapy: Qualitative analysis on therapeutic dancing classes for Parkinson’s. Complementary Therapies In Medicine, [s.l.], v. 34, p.1-9, out. 2017. Elsevier BV. http://dx.doi.org/10.1016/j.ctim.2017.07.006.
SCHLESINGER, Ilana et al. Parkinson's disease tremor is diminished with relaxation guided imagery. Movement Disorders, [s.l.], v. 24, n. 14, p.2059-2062, 30 out. 2009. Wiley. http://dx.doi.org/10.1002/mds.22671.
TOLSON, Debbie et al. International Association of Gerontology and Geriatrics: A Global Agenda for Clinical Research and Quality of Care in Nursing Homes. Journal Of The American Medical Directors Association, [s.l.], v. 12, n. 3, p.184-189, mar. 2011. Elsevier BV. http://dx.doi.org/10.1016/j.jamda.2010.12.013.PEARN, J; GARDNER-THORPE, C. James Parkinson (1755-1824): A pioneer of child care. Journal Of Paediatrics And Child Health, [s.l.], v. 37, n. 1, p.9-13, 11 fev. 2001. Wiley. http://dx.doi.org/10.1046/j.1440-1754.2001.00598.x.
TÖRNHAGE, Carl-johan et al. Short- and long-term effects of tactile massage on salivary cortisol concentrations in Parkinson’s disease: a randomised controlled pilot study. Bmc Complementary And Alternative Medicine, [s.l.], v. 13, n. 1, p.357-367, dez. 2013. Springer Nature.dono.
VALCARENGHI, Rafaela Vivian et al. The daily lives of people with Parkinson's disease. Revista Brasileira de Enfermagem, [s.l.], v. 71, n. 2, p.272-279, abr. 2018. FapUNIFESP (SciELO). http://dx.doi.org/10.1590/0034-7167-2016-0577.
XU, Qi et al. Epigallocatechin Gallate Has a Neurorescue Effect in a Mouse Model of Parkinson Disease. The Journal Of Nutrition, [s.l.], v. 147, n. 10, p.1926-1931, 23 ago. 2017. Oxford University Press (OUP). http://dx.doi.org/10.3945/jn.117.255034.
